Pallini, Greece

Eleni Stathaki

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Eleni Stathaki. Retrieved from https://idiyas.com/inventor/eleni-stathaki

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:

goldMedal1 out of 834,513 
Other
 patents

Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Eleni Stathaki: Innovator in Pharmaceutical Formulations

Introduction

Eleni Stathaki is a notable inventor based in Pallini, Greece. She has made significant contributions to the field of pharmaceuticals, particularly in the development of formulations that enhance the stability and efficacy of active ingredients.

Latest Patents

Eleni holds a patent for a pharmaceutical formulation containing an HMG-COA reductase inhibitor. This innovative formulation includes Fluvastatin, or its pharmaceutically acceptable salts, combined with a stabilizer made from a mixture of Carrageenans. The stabilizer plays a crucial role in inhibiting isomerization, elimination, oxidation, and recrystallization of the active ingredient, thereby improving its oral administration.

Career Highlights

Throughout her career, Eleni has focused on advancing pharmaceutical technologies. Her work has led to the development of improved formulations that are essential for effective treatment options in various medical conditions.

Collaborations

Eleni has collaborated with notable professionals in her field, including Evangelos Karavas and Efthimios Koutris. These partnerships have contributed to her innovative research and development efforts.

Conclusion

Eleni Stathaki's contributions to pharmaceutical formulations demonstrate her commitment to enhancing drug stability and efficacy. Her innovative work continues to impact the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…